Fundraising Fox
Charles Dunn
InvestorPrincipal at SV Health Investors
London
Writes $100K – $5M checks · typically $1.5M
Find your path to Charles
Sign up to see every warm intro you have to Charles
- Paths you didn't know you had: your email and LinkedIn already hold routes to Charles. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Charles Dunn joined SV Health Investors in 2018 as a Principal on the biotech team, where he helps form and fund companies developing new medicines across early creation to later-stage public and private opportunities. Before SV he qualified as an ACA after three years at Deloitte serving Life Sciences clients, and has an academic background in human genetics and molecular biology from UCL.
Contact· self-published, not guessed
Invests in
Biotech
Deals · 1
Draig TherapeuticsLed round
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Autifony TherapeuticsEnaraBioImbria PharmaceuticalsMestag TherapeuticsPulmocide
Per the firm's website.
Colleagues at SV Health Investors
Network7
Investors connected to Charles in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Charles Dunn?
- Charles Dunn joined SV Health Investors in 2018 as a Principal on the biotech team, where he helps form and fund companies developing new medicines across early creation to later-stage public and private opportunities. Before SV he qualified as an ACA after three years at Deloitte serving Life Sciences clients, and has an academic background in human genetics and molecular biology from UCL.
- Where does Charles Dunn work?
- Charles Dunn is Principal at SV Health Investors.
- What does Charles Dunn invest in?
- Charles Dunn invests in Biotech.
- What check size does Charles Dunn write?
- Charles Dunn typically writes checks of $100K – $5M.
- What boards does Charles Dunn sit on?
- Charles Dunn holds tracked board seats at Autifony Therapeutics, EnaraBio, Imbria Pharmaceuticals, Mestag Therapeutics, Pulmocide.
- What companies has Charles Dunn invested in?
- Investments tracked here include Draig Therapeutics.
- Does Charles Dunn lead rounds?
- Yes — Charles Dunn has led 1 tracked investment.
About this profile. Compiled from public sources — SV Health Investors's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights